Skip to main content

AutoGenomics, Gentris in Pharmacogenomics Development Pact

NEW YORK, July 27 (GenomeWeb News) - AutoGenomics and Gentris said today that they have begun a collaboration to develop pharmacogenomics diagnostic tools based on AutoGenomics' genomic testing platform.

 

Under the terms of the agreement, Gentris will integrate its CYP450 diagnostic products with AutoGenomics' Infiniti DNA and protein analysis platform.

 

Financial terms of the agreement were not provided.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.